Progress of specialized pro-resolving mediators in diabetic kidney disease

doi:10.16352/j.issn.1001-6325.2023.07.1152

Abstract

Abstract: Specialized pro-resolving mediators (SPMs) can promote the regression of chronic inflammatory response in diabetic kidney disease (DKD), inhibit renal fibrosis and protect renal function by inhibiting renal intrinsic cell inflammatory response, antioxidant stress injury and regulate macrophage transformation. With the in-depth study of SPMs, it is expected to become a new target for the treatment of chronic inflammatory diseases such as DKD.

Key words: specialized pro-resolving mediators, inflammatory regulation, pro-inflammatory resolution, diabetic kidney disease

CLC Number:

LIU Chong, LIU Yingying, GUO Zhaoan. Progress of specialized pro-resolving mediators in diabetic kidney disease[J]. Basic & Clinical Medicine, 2023, 43(7): 1152-1156.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.07.1152

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I7/1152

References

[1] Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, et al. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy[J]. Int J Mol Sci, 2020, 21:3798. doi:10.3390/ijms21113798.
[2] 邓九红,郑超,王声遥,等.醋酸泼尼松对糖尿病肾病模型大鼠肾功能、肾脏炎性反应及AMPK/SIRT1信号通路的影响[J].基础医学与临床,2022,42:243-248. doi:10.16352/j.issn.1001-6325.2022.02.006.
[3] Tang X, Liu L, Miao Z, et al. Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment[J]. Free Radic Biol Med. 2022,188:194-205. doi:10.1016/j.freeradbiomed.2022.06.231.
[4] Halade GV, Kain V, De La Rosa X, et al. Metabolic transformation of fat in obesity determines the inflamma-tion resolving capacity of splenocardiac and cardiorenal networks in heart failure[J]. Am J Physiol Heart Circ Physiol, 2022, 322: H953-H970. doi:10.1152/ajpheart.00684.2021.
[5] Li X, Xu B, Wu J, et al. Maresin 1 alleviates diabetic kidney disease via LGR6-mediated cAMP-SOD2-ROS pathway[J]. Oxid Med Cell Longev. 2022,2022:7177889. doi:10.1155/2022/7177889.
[6] Emre C, Hjorth E, Bharani K, et al. Receptors for pro-resolving mediators are increased in Alzheimer’s disease brain[J]. Brain Pathol. 2020,30:614-640. doi:10.1111/bpa.12812.
[7] Hughes Jr FM, Allkanjari A, Odom MR, et al. Specialized pro-resolution mediators in the bladder: receptor expres-sion and recovery of bladder function from cystitis[J]. Exp Biol Med (Maywood), 2022, 247: 700-711. doi:10.1177/15353702211067465.
[8] Liu Z, Qu M, Yang Q, et al. Lipoxin A4 ameliorates renal ischaemia-reperfusion-induced acute lung injury in rats[J]. Clin Exp Pharmacol Physiol, 2019, 46: 65-74. doi:10.1111/1440-1681.13023.
[9] Yu S, Xie J, Xiang Y, et al. Downregulation of TNF-α/TNF-R1 signals by AT-lipoxin A4 may be a significant mechanism of attenuation in SAP-associated lung injury[J]. Mediators Inflamm, 2019, 2019: 9019404. doi:10.1155/2019/9019404.
[10] Brennan EP, Mohan M, McClelland A, et al. Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease[J]. J Am Soc Nephrol, 2018, 29: 1437-1448. doi:10.1681/ASN.2017101112.
[11] Werz O, Gerstmeier J, Libreros S, et al. Human macrophages differentially produce specific resolvin or leuko-triene signals that depend on bacterial pathogenicity[J]. Nat Commun, 2018, 9: 1-12. doi:10.1038/s41467-017-02538-5.
[12] Yuan J, Lin F, Chen L, et al. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway[J]. Inflammopharmacology, 2022, 30: 487-498. doi:10.1007/s10787-022-00942-y.
[13] Scurt FG, Menne J, Brandt S, et al. Systemic inflamma-tion precedes microalbuminuria in diabetes[J]. Kidney Int Rep, 2019, 4: 1373-1386. doi:10.1016/j.ekir.2019.06.005.
[14] Wu X, Pan C, Chen R, et al. BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells[J]. Int Immunopharmacol, 2020, 79: 106108. doi:10.1016/j.intimp.2019.106108.
[15] Yang S, Zheng Y, Hou X.Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis[J]. Cell Signal, 2019, 60: 146-153. doi:10.1016/j.cellsig.2019.05.002.
[16] Bai Y, Wang J, He Z, et al. Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor β (TGF-β)/smad pathway and pro-inflammatory cytokines[J]. Med Sci Monit, 2019, 25: 3069-3076. doi:10.12659/MSM.914860.
[17] Yu S, Cheng Y, Zhang L, et al. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats[J]. Stem Cell Res Ther, 2019, 10: 1-18. doi:10.1186/s13287-019-1474-8.
[18] Li Z, Liu Z, Lu H, et al. RvD1 attenuated susceptibility to ischemic AKI in diabetes by downregulating nuclear factor-κB signal and inhibiting apoptosis[J]. Front Physiol, 2021,12:651645. doi:10.3389/fphys.2021.651645.
[19] Li G, Chen Z, Bhat OM, et al. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury[J]. J Lipid Res, 2017, 58: 1080-1090.
[20] Rund KM, Peng S, Greite R, et al. Dietary omega-3 PUFA improved tubular function after ischemia induced acute kidney injury in mice but did not attenuate impairment of renal function[J]. Prostaglandins Other Lipid Mediat, 2020, 146: 106386. doi:10.1016/j.prostaglandins.2019.106386.
[21] Sakai C, Ishida M, Ohba H, et al. Fish oil omega-3 polyunsaturated fatty acids attenuate oxidative stress-induced DNA damage in vascular endothelial cells[J]. PLoS One, 2017, 12: e0187934. doi:10.1371/journal.pone.0187934.
[22] Hu X, Liang Y, Zhao H, et al. Effects of AT-RvD1 on paraquat-induced acute renal injury in mice[J]. Int Immunopharmacol, 2019, 67: 231-238. doi:10.1016/j.intimp.2018.12.029.
[23] Calle P, Hotter G.Macrophage phenotype and fibrosis in diabetic nephropathy[J]. Int J Mol Sci, 2020, 21: 2806. doi:10.3390/ijms21082806.
[24] Shati AA, El-Kott AF, Alkhateeb MA.Resolvin D1 prevents cadmium chloride-induced memory loss and hippocampal damage in rats by activation/upregulation of PTEN-induced suppression of PI3K/Akt/mTOR signaling pathway[J]. Clin Exp Pharmacol Physiol, 2022, 49: 275-290. doi:10.1111/1440-1681.13596.
[25] Wang B, Wei J, Huangfu Q, et al. Identification of resolvin D1 and protectin D1 as potential therapeutic agents for treating kidney stones[J]. Oxid Med Cell Longev, 2022, 2022:4345037. doi:10.1155/2022/4345037.
[26] Tang S, Gao C, Long Y, et al. Maresin 1 mitigates high glucose-induced mouse glomerular mesangial cell injury by inhibiting inflammation and fibrosis[J]. Mediators Inflamm, 2017, 2017:2438247. doi:10.1155/2017/2438247.